The Journal of family practice
The most recent articles from:
J Fam Pract
-
Women ages 30 to 65 years now have a third cervical cancer screening option.
-
Randomized Controlled Trial
Does concurrent use of clopidogrel and PPIs increase CV risk in patients with ACS?
No. Adding a proton pump inhibitor (PPI) in patients taking antiplatelet medications such as clopidogrel for acute coronary syndrome (ACS) doesn't increase the composite risk of cardiovascular (CV) events: CV death, myocardial infarction (MI), and cerebrovascular accident (CVA) (strength of recommendation: B, randomized, controlled trial [RCT] and prepon-derance of posthoc analyses of large RCTs).
-
Was a drug or a comorbidity to blame for this patient's hyperpigmentation?